By integrating multi-layered omics data with experimental validation, future studies can extend these findings to delineate Hsp90β’s roles not only in cancer resistance but also in normal cellular biology and tissue-specific proteostasis, an important and understudied aspect of Hsp90β function in the context of Hsp90 isoform-selective inhibitors. Here, HSP90AB1 is linked to cancer.